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In the United States, preterm birth (PTB) accounts for 9.6% of
live births and is the leading cause of infant morbidity and
mortality in nonanomalous infants.1 PTB poses a significant
economic burden of up to $26 billion to care for these infants
in the United States. Primary prevention strategies such as
antioxidant supplementation or screening and treatment of
maternal infections have failed to reduce or eliminate spon-
taneous PTB (sPTB).2 To date, much of the focus in under-
standing PTB has focused on maternal factors that incite
preterm labor, such as inflammation, infection, andmaternal
decidual or endometrial factors,3 and not on possible con-






Abstract Objective To analyze the transcriptomic gene expression of umbilical cord blood
leukocytes using RNA-sequencing from preterm birth (PTB) and term birth (TB).
Study Design Eight women with spontaneous PTB (sPTB) and eight women with
unlabored TB were enrolled prospectively. The sPTB and TB cohorts were matched for
maternal age, race,mode of delivery, and fetal sex. Cord blood RNAwas extracted and a
globin depletion protocol was applied, then sequenced on the Illumina HiSeq 4000.
Raw read counts were analyzed with DESeq2 to test for gene expression differences
between sPTB and TB.
Results 148 genes had significant differential expression (q < 0.01). Cell cycle/
metabolism gene expression was significantly higher and immune/inflammatory
signaling gene expression significantly lower in the sPTB cohort compared with
term. In African American (AA) infants, 18 genes specific to cell signaling, neutrophil
activity, and major histocompatibility complex type 1 had lower expression in preterm
compared with term cohort; the opposite pattern was seen in non-Hispanic Whites
(NHWs).
Conclusion Compared with term, preterm fetuses have higher cell cycle/metabolism
gene expression, suggesting metabolic focus on growth and development. Immune
function gene expression in this pilot study is lower in the sPTB group compared with
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contribution to sPTB; however, there are emerging data that
show that variants in the DNA of the fetus, not the mother,
may be the trigger for some PTBs.4 Identifying transcrip-
tomic signatures at the fetal molecular level by examining
differentially expressed genes between preterm and term
cohorts using RNA-sequencing (RNA-seq) fills the knowl-
edge gaps in our understanding of the fetal contribution to
pregnancy-specific disorders such as sPTB.
New and emerging high throughput next-generation
genomic technologies have led to the ability to sequence
messenger RNA, permitting interrogation of the entire fetal
transcriptome in umbilical cord blood. The transcriptome is
the sum total of messenger RNA expressed in a tissue.
Transcriptome analysis captures a snapshot of cellular activ-
ity that reflects the response to genetic, environmental, and
epigenetic changes in a biological system. Knowledge of the
transcriptome allows for the quantification and assessment
of genes thatmay be active in different disease processes and
at various stages of development.5 This technology has been
applied to cancer therapeutics and diagnostics6 leading to
new insights and therapeutics. While transcriptomics has
been studied in pregnancy conditions such as sPTB, pre-
eclampsia, and obesity among others,7–9 this field is still
emerging in terms of shedding light on the molecular under-
pinnings of these complex pregnancy disorders.
The objective of the study was to measure fetal gene
expression from umbilical cord blood at the time of delivery
in term and preterm pregnancies to identify differentially
regulated genes related to common PTB pathways, such as
inflammation, immune function, and oxidative stress.
Our second objective was to evaluate differences in gene
expression in preterm compared with term fetuses to gain
insight into fetal development. We hypothesized that fetal
genes are differentially expressed in common PTB pathways
following sPTB compared to term birth (TB). These findings
have the potential to increase our understanding of the fetal
molecular contribution to sPTB, and will lay the foundation
to improve diagnosis, prognosis, and therapeutic strategies
in obstetrics and pediatrics.10
Methods
The studywas approved by the University of North Carolina at
Chapel Hill Institutional Review Board. This prospective case–
control study included eight women who delivered via idio-
pathic sPTB (<34 weeks) and eight women who delivered at
term (>37weeks) with singleton fetuses who delivered at the
University of North Carolina at Chapel Hill. Preterm labor was
defined as the presence of regular uterine contractions and
documented cervical effacement and/or dilatation in patients
<37 weeks’ gestational age (GA). The preterm patients were
admitted to the antepartum service and presented with pre-
term contractions. TB was defined as delivery at greater than
37 weeks gestationwith no labor. Preterm premature rupture
of membranes (PPROM) was confirmed by vaginal “pooling,”
and positive “nitrazine” or “ferning” tests.11
The sPTB and TB cohorts were matched for factors that
could affect fetal gene expression including: maternal age,
race, fetal sex, medication exposure except for glucocorti-
coids (all women in the sPTB received betamethasone as per
American College of Obstetricians and Gynecologists’ guide-
lines), and mode of delivery (all women had cesarean sec-
tions). Pertinent clinical information about the patients is
provided in ►Table 1. Term patients were enrolled prior to
elective cesarean delivery at term (390/7 to 396/7 weeks). All
preterm infants received steroids prior to delivery with the
median number of days from administration of steroids to
delivery of 2.18 (range: 1–19 days). Four of the preterm
fetuses were born via sPTB after PPROM with the median
number of days from rupture to delivery of 16 (range: 3–38
days). The phenotype of sPTBwas limited towomenwho had
spontaneous labor with or without PPROM. Patients with
abruption, diabetes, clinical chorioamnionitis, fetal anoma-
lies, and medication exposures were excluded because these
factors can all affect neonatal gene expression. Clinical
chorioamnionitis was defined by fever of38.0°C in addition
to at least two other signs of chorioamnionitis, including
uterine fundal tenderness, maternal tachycardia (>100
per minute), fetal tachycardia (>160 per minute), and puru-
lent or foul-smelling amniotic fluid.
Power studies of gene expression using DESeq2 have
shown that eight cases and controls are a sufficient number
to have adequate power to detect significant differential gene
expression between dichotomous groups (term/preterm).12
It was not possible to match by GA or glucocorticoid expo-
sure as this would be unethical given the known benefits of
glucocorticoids in preterm infants. A post hoc power analysis
with ssizeRNA shows that we have 70% power to detect a
twofold difference in gene expression based on the average
number of counts (1,296) and dispersion (0.167) as esti-
mated from the data, and the Benjamini–Hochberg false
discovery rate (FDR) of 5%.13 For the analyses performed
by race, there was inadequate power to detect significant
differences but analysis was performed to identify trends
and generate hypotheses to test in future studies.
Umbilical cord bloodwas collected in RNA PAXgene tubes
and stored at 80°C. The PAXgene blood tubes stabilize




















Fetal sex (number of
males, number of
females)
6, 2 6, 2
Cesarean sections 8 8
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intracellular RNA and in processing the tubes, intact cells are
pelleted and RNA extracted. Total RNA was extracted from
whole blood using a PAXgene Blood miRNA kit on the
QIAcube. A globin depletion protocol using custom Human
Globin AnyDeplete (NuGEn) probes enriched with fetal
globin gene primers was applied to reduce uninformative
reads, enabling more RNA transcripts to be detected. Quality
control was performed for all samples using the LabChip GX
system. All samples were handled in a uniform way by one
technician. Universal Plus mRNA-seq library prep kit
(NuGen) was used to generate mRNA-seq libraries from
500-ng umbilical cord blood total RNA. Cord blood (coding
and noncoding) was sequenced on the Illumina HiSeq 4000
PE 2  50. Sequencing reads were analyzed as follows:
chastity filtered reads were aligned to hg38 using single
pass STAR14 with default parameters and transcript abun-
dance estimates for each sample were estimated with Sal-
mon15,16 to quantify the transcriptome defined by Gencode
v22. Gene level countswere summed across isoforms and the
resulting gene count estimateswere analyzedwith DESeq217
to test for differences between sPTB and TB adjusted for race.
Race was modeled as an additive covariate, and sPTB versus
TB effects were tested using the DESeq2 version 1.4.5 like-
lihood ratio test comparing the bivariate model of race and
birth to a reduced model of just race. Significant differences
in gene expression were defined by a Benjamini–Hochberg
FDR (q-value) <0.1 for the primary outcome (GA).18 Indivi-
dual cellular fractions by race and GA were estimated by
xCell followed by association testing with a linear model.19
Gene set analysis was performed to identify differentially
expressed pathways.20 The Gene Set Analysis in R (GSAR) is
an open-source R/Bioconductor software package for gene
set analysis. A gene set is a group of genes that shares
pathways, functions, chromosomal localization, or other
features.
Hierarchical clustering and principal component ana-
lysis. Two-dimensional unsupervised hierarchical cluster-
ing, dendrogram generation, and heat-map plotting were
performed using the pheatmap R package version 0.7.7. A
complete linkage algorithm with Manhattan distance func-
tionwas applied to normalized, log2transformed fold change
data for statistically significant differentially expressed
RNAs. Principal component analysis for differentially
expressed transcripts was accomplished using the ‘prcomp
()’ function in R version 3.0.3, in which a singular value
decomposition algorithm was applied to a centered and
scaled correlation matrix of normalized, log2transformed
fold change RNA-seq data. Three-dimensional scatterplots of
the first three principal components (PC1, PC2, PC3) were
generated using SigmaPlot version 12.5 (Systat Software, San
Jose, CA; ►Supplementary Fig. 1).
Results
RNA-seq was performed on cord blood collected from TB
(n ¼ 8) and sPTB (n ¼ 8) events. The median RNA integrity
number (RIN) value of the cord blood samples was 8.5
(range: 7–10); there was no statistical difference in RIN
values between cases and controls. Fetal sex and maternal
race displayed onlyminor effects on transcript abundance as
fetal sex was associated with only two genes (XIST and TSIX)
and race with none at the specified criteria.
One hundred and forty eight genes were differentially
expressed in the setting of sPTB compared with TB. Two
pathways, cell cycle/metabolism and immune/inflammatory
signaling, represent the predominant pathways with signif-
icant differential expression in the preterm versus term
cohorts. Cell cycle/metabolism (e.g., electron transport
chain) gene expression was significantly higher (z-score
¼ 18–24), and immune/inflammatory signaling gene
expression (cytokines, interleukins, and T-helper cells) was
significantly lower (z-score ¼ 41 to 26) in the sPTB cord
blood compared with term (►Figs. 1 and 2).
Exploratory analysis was performed to investigate inter-
actions of GA with race. The results yielded 18 genes
decreased in preterm African American (AA) infants and
increased in term AA infants (q < 0.1). However, the oppo-
site pattern was seen in non-Hispanic White (NHW) pre-
term/term infants (►Fig. 3). These included genes associated
with cell signaling, neutrophil activity, and major histocom-
patibility complex type 1: DmX-like protein 2 (DMXL2),
ubiquitin-like modifier ISG15 (ISG15), and butyrophilin sub-
family 3 member A2 (BTN3A2).
Gene expression data were evaluated using xCell to
quantify a variety of cellular phenotypes. There were no
differences between leukocyte/lymphocyte compositions of
the preterm and term fetal cord blood; however, we were
underpowered to detect a difference. Preterm infants had
significantly lower macrophage gene expression (p ¼ 0.001)
compared with term infants. This cellular composition ana-
lysis testing for race-dependent effects showed that preterm
and term AA infants had lower native CD4 T-cell gene
expression compared with NHW infants (p ¼ 0.01; ►Fig. 4).
Fig. 1 Heat map of gene expression of electron transport chain gene
expression. Gray (top) represents preterm samples and red represents
term samples. Blue color on the heat map represents low gene
expression and yellow color represents high gene expression.
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Half of the preterm placentas and cords showed evidence
of chorionitis and funisitis even though none of the patients
had clinical chorioamnionitis. None of the neonates had
sepsis. All of the term infants transitioned to room air
without difficulty, had Apgar scores at 1 and 5 minutes of
>8, and did well clinically.
Discussion
Our findings that immune and inflammatory gene expres-
sions were higher in term compared with preterm infants
provide novel insights into fetal development and fetal gene
expression in sPTB compared with TB. While other authors
studied PTB by focusing on gene expression changes in
maternal whole blood,8 we chose to focus on umbilical
cord blood samples as they are representative of the in utero
environment of a neonate shortly before birth. While other
investigators have examined gene expression via microarray
in amniotic fluid supernatant,21 a few have performedwhole
transcriptome analyses using RNA-seq from cord blood,10
and none to date have done this on preterm infants following
sPTB. Our findings suggest that despite the inflammatory
milieu so commonly seen in sPTB, preterm infants born due
to sPTB had lower gene expression of immune/inflammatory
signaling function compared with term infants. This finding
alone is not surprising as the immune system is immature in
preterm infants and not even fullymature at the time of TB as
the adaptive immune system must develop specificity and
memory, which does not occur until the early childhood
years.22,23 We found fetal genes associated with inflamma-
tion were down-regulated in the infants born preterm com-
pared with term despite previously published clinical and
experimental data showing ameasurable fetal inflammatory
response following preterm labor and other inflammatory
processes.24
In fact, our group found that even prior to the onset of
symptoms of sPTB, there is evidence of a fetal inflammatory
response. In a previous study,we extracted cell-free fetal (cff)
Fig. 3 Heat map of gene expression showing significantly different
gene expression patterns in AA and NHW. Gray (top) represents
preterm samples and red represents term samples. Blue color
represents low gene expression and yellow color represents high gene
expression.
Fig. 4 CD4þ naïve T-cells. Preterm and term AA infants have lower
CD4 T-cell gene expression compared with term infants (p ¼ 0.01).
Fig. 2 Heat map of gene expression with regard to T-cell receptor
gene expression. Gray (top) represents preterm samples and red
represents term samples. Blue color represents low gene expression
and yellow color represents high gene expression.
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RNA from amniotic fluid supernatant and used a customized
nanostring panel containing genes related to common PTB
pathways (oxidative stress and inflammation) and compared
gene expression in fetuses who delivered preterm and those
who delivered at term. Compared with fetuses who ulti-
mately delivered at term, fetuses who delivered preterm had
significantly increased gene expression of β-2 microglobulin
in amniotic fluid, a marker of the fetal inflammatory
response.25
Thequestion thenarises regardingwhyotherdata including
data fromour laboratory showevidenceofa fetal inflammatory
response and this cohort does not. We hypothesize several
possible reasons. Previous studies includingour ownmeasured
gene expression via cff RNA in amniotic fluid;21,25 this study
uses RNA extracted from cord blood. Gene expression in two
different biofluids and from two different forms of RNA (cff
RNA vs. RNA) can differ. The gene expression from RNA in
amnioticfluid supernatant is a reflection of gene expression in
various fetal secretions including from urine, saliva, and tra-
cheal secretions compared with gene expression found in
umbilical cordblood. Prior studies using amnioticfluid showed
that the regulationofgeneexpressionvaries extensivelyamong
fetal tissues with skeletal and muscular system development
and function, tissue development, and hematological system
development and function having higher gene expression
compared with other organ systems.26 In our study using
umbilical cord blood, we also noted differential gene expres-
sion in genes related to tissue development and hematological
system development. Previous studies using amniotic fluid
supernatant made use of customized nanostring panels or
microarrays that had limited gene coverage. Our data using
RNA-seq suggest that preterm infants in utero have lower gene
expression specific to immune/inflammatory response at the
timeofsPTB. Thequestionthenariseswhether this results inan
inability to mount an immune response or contributes to PTB,
which cannot be ascertained by our study.
There are multiple strengths to using RNA-seq from
umbilical cord blood compared with using cff RNA from
amniotic fluid supernatant to understand fetal disease pro-
cesses. These include (1) less degradation of RNA compared
with amnioticfluid supernatant and higher quality of cellular
RNA compared with cff RNA; (2) ability to identify alter-
native splicing; and (3) identification of specific biological
pathways from comprehensive interrogation of the genome.
Given the ability to interrogate the whole transcriptome
robustly with RNA-seq of umbilical cord blood, RNA-seq
methods have the potential to identify dysregulated genes
specific to certain pregnancy conditions as described in the
current study with more sensitive detection of genes, tran-
scripts, and differential expression compared with pre-
viously published methods using cff RNA and microarrays.
This study also sheds light on in utero developmental
factors. Compared with term, preterm infants have higher
cell cycle and metabolism gene expression, suggesting a
metabolic focus on growth and development. Other studies
confirmed differential gene expression related to GA with
term fetuses showing enrichment of salivary gland, tracheal,
and renal transcripts as comparedwith brain and embryonic
neural cells in the second trimester.27 Functional analysis of
genes upregulated at term in amniotic fluid supernatant
revealed pathways that were highly specific for postnatal
adaptation such as immune function, digestion, respiration,
carbohydratemetabolism, and adipogenesis.21 Similar to the
current study using cord blood, inflammation, a key process
involved in normal labor, has been also shown to increase in
studies using term amniotic fluid.21
There are other intriguing findings from this study to
highlight. We did not identify any increase in gene expres-
sion related to the neonatal hypothalamic pituitary adrenal
(HPA) axis gene expression in the sPTB cohort. Corticotropin-
releasing hormone (CRH), a hypothalamic neuropeptide that
regulates HPA axis activity, is integral to the regulation of
labor. There is a premature surge of CRH levels in the
amniotic fluid, placenta, and fetal membranes among preg-
nancies of women who deliver preterm. Fetal HPA axis
activation is a potential therapeutic target pathway for
sPTB prevention. However, we found no alteration in gene
expression in HPA gene expression in preterm versus term
neonates. All of the preterm infants received betamethasone
prior to delivery, which has also been shown to suppress fetal
HPA axis function.28–30 We also found racial/ethnic differ-
ences in gene expression related to immune-mediated cell
signaling. Racial disparities exist in neonatal sepsis, with
infants of AAwomen having higher rates of neonatal sepsis at
term and preterm compared with infants of NHW
mothers.31,32 Cell composition analysis showed that white
blood cell gene expression also differed in both term and
preterm AA infants compared with NHW infants. These
findings warrant further investigation and we hypothesize
that epigenetic mechanisms may be responsible for this
discrepant pattern.
There are limitations of the current study. The small
sample size allowed us enough power to detect differential
gene expression between dichotomous groups but we were
not powered to detect differences by race or fetal sex. Despite
this, we showed evidence of differential gene expression by
race. However, it is possible that this difference between
races is a false-positive result (despite the use of statistical
methods to minimize the chance of FDRs) due to normal
variations in the human population. A larger sample size
with validation of results by reverse transcription-polymer-
ase chain reaction (RT-qPCR) is needed to further study this
finding. Because we recruited patients in real clinical situa-
tions, fetuses bornwere exposed to antenatal corticosteroids
which can change fetal gene expression.33However, the data
on fetal gene expression changes with antenatal corticoster-
oids are limited to murine and in vivo studies with minimal
data on humans.33 It is also possible that chorioamnionitis
was present despite no clinical signs of chorioamnionitis.
Half of the preterm placentas showed evidence of chorionitis
and funisitis. However, this is neither a sensitive nor specific
screening test for chorioamnionitis. To the best of our ability,
we limited variability in the cohorts which could alter gene
expression. However, a limitation inherent in the study
design was differences in GAs. This may contribute to
some of the changes that were observed in this study, which
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may be caused by different developmental stages. However,
for practical and ethical reasons, relative matching was
considered to be the most reasonable alternative for our
study. Other authors have overcome this limitation by com-
paring the human placental transcriptome to the macaque
placental transcriptome at equivalent GAs because maca-
ques are closely related to humans.34 Another limitationwas
that we included women who had premature rupture of
membranes (PROM) prior to onset of labor. Half of the
preterm cohort had PROM and the other half had sponta-
neous labor. Because we enrolled patients who were in
spontaneous labor with or without PROM with 50% of the
sPTB cohort delivering after PROM, there was heterogeneity
in the cohort. Further work to study differences may be
accomplishedwith use of noninvasively obtained cff RNA in a
larger cohort of patients.
In summary, RNA-seq of umbilical cord blood leukocytes
can identify novel insights in neonates born via sPTB and TB.
PTB prevention remains elusive because the mechanisms
driving spontaneous preterm labor are poorly understood.
Identification of differences in gene expression between
preterm and term fetuses will lay the groundwork for future
prospective studies to delineate mechanisms leading to
sPTB, ultimately allowing development of novel prevention
strategies. For example, if decreased immune function in
preterm fetuses is a contributing factor to sPTB, novel
strategies can be developed to bolster the fetal immune
system. These novel pharmacologic interventions can be
tested in animal models. This is the first of many steps
necessary to better understand the mechanism of sPTB
and ultimately lead to effective preventive strategies.
Statement of Financial Support
BIRCWH K12 HD001441 funded by NICHD (PI: Boggess);
NICHD R03 HD080788 (PI: Vora); NICHD K23 HD088742
(PI: Vora); NCATS NIH UL1TR001111. The National Insti-
tutes of Health had no involvement in the study design,
collection of specimens, analysis, interpretation of the
data, writing of manuscript, or decision to submit the
article for publication.
Conflict of Interest




1 Martin JA, Hamilton BE, Osterman MJ, Driscoll AK, Mathews TJ.
Births: final data for 2015. Natl Vital Stat Rep 2017;66(01):1
2 MarkhamKB, KlebanoffM. Prevention of pretermbirth inmodern
obstetrics. Clin Perinatol 2014;41(04):773–785
3 Norwitz ER, Bonney EA, Snegovskikh VV, et al. Molecular regula-
tion of parturition: the role of the decidual clock. Cold SpringHarb
Perspect Med 2015;5(11):a023143
4 Biggio J, Xiao F, Baldwin D, et al. Neonatal, not maternal, copy
number variants are associated with spontaneous preterm birth.
Am J Obstet Gynecol 2015;212(1, Suppl):S8
5 Byron SA, Van Keuren-Jensen KR, Engelthaler DM, Carpten JD,
Craig DW. Translating RNA sequencing into clinical diagnostics:
opportunities and challenges. Nat Rev Genet 2016;17(05):
257–271
6 Mody RJ, Wu YM, Lonigro RJ, et al. Integrative clinical sequencing
in the management of refractory or relapsed cancer in youth.
JAMA 2015;314(09):913–925
7 Bukowski R, Sadovsky Y, Goodarzi H, et al. Onset of human
preterm and term birth is related to unique inflammatory tran-
scriptome profiles at the maternal fetal interface. PeerJ 2017;5:
e3685
8 Paquette AG, Shynlova O, Kibschull M, Price ND, Lye SJ; Global
Alliance to Prevent Prematurity and Stillbirth Systems Biology of
Preterm Birth Team. Comparative analysis of gene expression in
maternal peripheral blood and monocytes during spontaneous
preterm labor. Am J Obstet Gynecol 2018;218(03):345.e1–345.
e30
9 Eidem HR, Ackerman WE IV, McGary KL, Abbot P, Rokas A.
Gestational tissue transcriptomics in term and preterm human
pregnancies: a systematic review and meta-analysis. BMC Med
Genomics 2015;8:27
10 Maron JL, Dietz JA, Parkin C, Johnson KL, Bianchi DW. Performing
discovery-driven neonatal research by transcriptomic analysis of
routinely discarded biofluids. J Matern Fetal Neonatal Med 2012;
25(12):2507–2511
11 Practice bulletins No. 139: premature rupture of membranes.
Obstet Gynecol 2013;122(04):918–930
12 Ching T, Huang S, Garmire LX. Power analysis and sample size
estimation for RNA-Seq differential expression. RNA 2014;20
(11):1684–1696
13 Bi R, Liu P. Sample size calculation while controlling false dis-
covery rate for differential expression analysis with RNA-sequen-
cing experiments. BMC Bioinformatics 2016;17:146
14 Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal
RNA-seq aligner. Bioinformatics 2013;29(01):15–21
15 Bullard JH, Purdom E, Hansen KD, Dudoit S. Evaluation of statis-
tical methods for normalization and differential expression in
mRNA-Seq experiments. BMC Bioinformatics 2010;11:94
16 Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon
provides fast and bias-aware quantification of transcript expres-
sion. Nat Methods 2017;14(04):417–419
17 LoveMI, HuberW, Anders S. Moderated estimation of fold change
and dispersion for RNA-seq datawith DESeq2. Genome Biol 2014;
15(12):550
18 Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the
false discovery rate in behavior genetics research. Behav Brain Res
2001;125(1–2):279–284
19 Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue
cellular heterogeneity landscape. Genome Biol 2017;18(01):220
20 Rahmatallah Y, Zybailov B, Emmert-Streib F, Glazko G. GSAR:
bioconductor package for gene set analysis in R. BMC Bioinfor-
matics 2017;18(01):61
21 Hui L, Wick HC, Edlow AG, Cowan JM, Bianchi DW. Global gene
expression analysis of term amniotic fluid cell-free fetal RNA.
Obstet Gynecol 2013;121(06):1248–1254
22 Maródi L. Innate cellular immune responses in newborns. Clin
Immunol 2006;118(2–3):137–144
23 Hannet I, Erkeller-Yuksel F, Lydyard P, Deneys V, DeBruyère M.
Developmental and maturational changes in human blood lym-
phocyte subpopulations. Immunol Today 1992;13(06):215–218
24 Gotsch F, Romero R, Kusanovic JP, et al. The fetal inflammatory
response syndrome. Clin Obstet Gynecol 2007;50(03):652–683
25 Vora NL, Smeester L, Boggess K, Fry RC. Investigating the role of
fetal gene expression in preterm birth. Reprod Sci 2017;24(06):
824–828
26 Hui L, Slonim DK,Wick HC, Johnson KL, Bianchi DW. The amniotic
fluid transcriptome: a source of novel information about human
fetal development. Obstet Gynecol 2012;119(01):111–118
American Journal of Perinatology Reports Vol. 9 No. 1/2019
RNA-Sequencing to Investigate Spontaneous Preterm Birth Vora et al. e65
27 Zwemer LM, Bianchi DW. The amniotic fluid transcriptome as a
guide to understanding fetal disease. Cold Spring Harb Perspect
Med 2015;5(04):a023101
28 Waffarn F, Davis EP. Effects of antenatal corticosteroids on the
hypothalamic-pituitary-adrenocortical axis of the fetus and new-
born: experimental findings and clinical considerations. Am J
Obstet Gynecol 2012;207(06):446–454
29 Leung TN, Chung TK, Madsen G, McLean M, Chang AM, Smith R.
Elevated mid-trimester maternal corticotrophin-releasing hor-
mone levels in pregnancies that delivered before 34 weeks. Br J
Obstet Gynaecol 1999;106(10):1041–1046
30 Challis J, Sloboda D, Matthews S, et al. Fetal hypothalamic-
pituitary adrenal (HPA) development and activation as a deter-
minant of the timing of birth, and of postnatal disease. Endocr Res
2000;26(04):489–504
31 Claydon JE, Mitton C, Sankaran K, Lee SK; Canadian Neonatal
Network. Ethnic differences in risk factors for neonatal mortality
and morbidity in the neonatal intensive care unit. J Perinatol
2007;27(07):448–452
32 Fiscella K. Racial disparity in infant and maternal mortality:
confluence of infection, and microvascular dysfunction. Matern
Child Health J 2004;8(02):45–54
33 Baisden B, Sonne S, Joshi RM, Ganapathy V, Shekhawat PS.
Antenatal dexamethasone treatment leads to changes in gene
expression in a murine late placenta. Placenta 2007;28(10):
1082–1090
34 Eidem HR, Rinker DC, Ackerman WE IV, et al. Comparing human
and macaque placental transcriptomes to disentangle preterm
birth pathology from gestational age effects. Placenta 2016;
41:74–82
American Journal of Perinatology Reports Vol. 9 No. 1/2019
RNA-Sequencing to Investigate Spontaneous Preterm Birth Vora et al.e66
